Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humans

Cytokine

Volumn 52, Issue 3, 2010, Pages 190-193

  Hari Sai Priya, V ^a   Suman Latha, G ^a   Hasnain, Seyed E ^c   Murthy, K J R ^a   Valluri, Vijaya Lakshmi ^a,b  

^a Bhagwan Mahavir Medical Research Centre   (India)

^b LEPRA Society   (India)

^c UNIVERSITY OF HYDERABAD   (India)

Author keywords

IFN ; Recombinant 32 kDa M. bovis BCG; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; RECOMBINANT ANTIGEN; BACTERIAL ANTIGEN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM BOVIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; VOLUNTEER; BIOSYNTHESIS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

ANTIGENS, BACTERIAL; BCG VACCINE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 79952229049     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.07.001     Document Type: Article

References (24)

1. Boesen H., Jensen B.N., Wilcke T., Andersen P. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 1995, 63:1491-1497.
2. Nikokar Iraj, Makvandi Manouchehr, Javad Kajbaf Mohammad, Farajzadeh Ahmad, Mirsaeidi Medhi, Kamali-Sarvestani Eskandar, et al. Evaluation of cellular immune response against purified antigen 85 in patients with tuberculosis. Iran J Immunol 2006, 70-77:2.
3. Hari Sai Priya V., Anuradha B., Suman Latha G., Hasnain Seyed E., Murthy K.J.R., Valluri Vijaya Lakshmi In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin Vaccine Immunol 2009, 16:111-115.
4. Torres M., Mendez-Sampeiro P., Jimenez-Zamudio L., et al. Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 1994, 96:75-78.
5. Hirsch C.S., Hussain R., Toossi Z., Dawood G., Shahid F., Ellner J.J. Cross-modulation by transforming growth factor b in human tuberculosis: suppression of antigen-driven blastogenesis and interferon g production. Proc Natl Acad Sci USA 1996, 93:3193-3198.
6. Toossi Z., Kleinhenz M.E., Ellner J.J. Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 1986, 163:1162-1172.
7. Barnes P.F., Chatterjee D., Abrams J.S., et al. Cytokine production by Mycobacterium tuberculosis lipoarabinomannan: relationship to chemical structure. J Immunol 1992, 149:541-547.
8. Ogawa T., Uchida H., Kusumoto Y., Mori Y., Yamamura Y., Hamada S. Increase in tumor necrosis factor alpha - and interleukin-6 - secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991, 59:3021-3025.
9. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun. 1994, 62:2536-2544.
10. Pal P.G., Horwitz M.A. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992, 60:4781-4792.
11. Wiker H.G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992, 56:648-661.
12. Kremer L., Maughan W.N., Wilson R.A., Dover L.G., Besra G.S. The M. tuberculosis antigen 85 complex and mycolyltransferase activity. Lett Appl Microbiol 2002, 34:233-237.
13. Anuradha B., Santosh C.M., Hari Sai Priya V., Suman Latha G., Murthy K.J.R., Valluri Vijaya Lakshmi Age-related waning of in vitro interferon levels against r32KDaBCG in BCG vaccinated children. J Immune Based Ther Vaccines 2007, 5:8.
14. Vijaya Lakshmi V., Kumar Sunil, Surekha Rani H., Suman Latha G., Murthy K.J.R. Tuberculin specific T cell responses in BCG vaccinated children. Indian Pediatr 2005, 42:36-40.
15. Vijaya L.V., Rao D.V., Murthy K.J.R., Jain S.N. Study of the tuberculin test and its correlation with the in vitro responses. Lung India 1989, 2:63-66.
16. Vijaya L.V., Murthy K.J.R., Rao D.V., Jain S.N. A study of the tuberculin test II: its correlation with the in vitro humoral responses. Lung India 1990, 2:69-71.
17. McShane H., Pathan A.A., Sander C.R., Keating S.M., Gilbert S.C., Huygen K., et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004, 10:1240-1244.
18. Anuradha B., Rakh S.S., Ishaq M., Murthy K.J.R., Valluri V.L. Interferon-γ low producer genotype +874 overrepresented in bacillus Calmette-Guerin nonresponding children. Pediatr Infect Dis J 2008, 27:325-329.
19. Huygen K., Vanvooren J.P., Turner M., Bosmans R., Dierck P., De Bruyn J. Specific lymphoproliferation, gamma interferon production and serum immunoglobulin G directed against a purified 32-kD antigen P32 in patients with tuberculosis. Scand J Immunol 1988, 27:187-194.
20. Torres Martha, Herrera Teresa, Villareal Hector, Rich Elizabeth A., Sada Eduardo Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998, 66:176-180.
21. Sahiratmadja E., Alisjahbana B., de Boer T., Adnan I., Maya A., Danusantoso H., et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007, 75:820-829.
22. Pathan A.A., Wilkinson K.A., Klenerman P., McShane H., Davidson R.N., Pasvol G., et al. Direct ex vivo analysis of antigen-specific IFNγ secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001, 167:5217-5225.
23. Ravn P., Munk M.E., Andersen A.B., Lundgren B., Lundgren J.D., Nielsen L.N., et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005, 12:491-496.
24. Hasan Z., Jamil B., Ashraf M., Islam M., Yusuf M.S., Khan Javaid A., Rabia Hussain ESAT6-induced IFNc and CXCL9 can differentiate severity of tuberculosis. PLoS ONE 2009, 4(4):e5158. 10.1371/journal.pone.0005158.